PEAK PERFORMANCE

Months to result

Clinical Trials Framework

Testing Therapies

Problem it solves

Clinical Trials Framework solves the gap between potential and actual performance by providing a structured approach to measuring, improving, and sustaining high output.

Best for

Researchers and clinicians

Not ideal for

General public

Overview

Why this framework exists

The Clinical Trials Framework is a structured approach to testing the safety and efficacy of new therapies, including psychedelic-assisted therapy. It involves multiple phases, including phase III trials, which are licensing trials. The framework is crucial for ensuring that new therapies are safe and effective before they are approved for use.

Core principles

3 total

Therapies must be tested in a controlled and rigorous manner.
Phase III trials are licensing trials that determine whether a therapy is safe and effective.
Regulatory oversight is essential for ensuring the safety and efficacy of new therapies.

Steps

3 steps

Phase I Trials
Initial trials to test the safety of a new therapy.
Pro tipPhase I trials are typically small and focused on safety.
WarningPhase I trials may not be representative of the larger population.
Phase II Trials
Trials to test the efficacy of a new therapy.
Pro tipPhase II trials are larger than phase I trials and focus on efficacy.
WarningPhase II trials may not be sufficient to determine long-term safety and efficacy.
Phase III Trials
Licensing trials to determine whether a therapy is safe and effective.
Pro tipPhase III trials are large and rigorous, and determine whether a therapy is approved for use.
WarningPhase III trials are expensive and time-consuming.

Checklist

Saved in your browser

Ensure that therapies are tested in a controlled and rigorous manner.
Provide adequate training for clinicians and researchers.
Ensure regulatory oversight to ensure the safety and efficacy of new therapies.

Examples

2 cases

MDMA-Assisted Therapy

MDMA-assisted therapy has been tested in phase III trials and has shown promising results for the treatment of post-traumatic stress disorder.

OutcomeThe therapy has been shown to be safe and effective, with a high remission rate.

Psilocybin-Assisted Therapy

Psilocybin-assisted therapy is currently being tested in phase III trials for the treatment of treatment-resistant depression.

OutcomeThe therapy has shown promising results, but more research is needed to determine its safety and efficacy.

Common mistakes

3 traps

Insufficient Testing

Failing to test a therapy in a rigorous and controlled manner can lead to unsafe or ineffective treatments.

Lack of Regulatory Oversight

Failing to ensure regulatory oversight can lead to unsafe or ineffective treatments.

Inadequate Training

Failing to provide adequate training for clinicians and researchers can lead to unsafe or ineffective treatments.

Origin story

How this framework came to be

The Clinical Trials Framework has been developed over decades, with the first phase III trials for psychedelic-assisted therapy currently underway. The framework is based on the principles of rigorous scientific testing and regulatory oversight.

Source

Traced to primary

Source · PODCAST

The Science of Psychedelics for Mental Health | Dr. Robin Carhart-Harris

Andrew Huberman · 2023

Open source →

Related frameworks

Browse all Peak Performance →